Two anti-inflammatory compounds shown to be capable of accelerating recovery from COVID-19
Two independent clinical studies—one by researchers at the Center for Cell-Based Therapy (CTC) in Ribeirão Preto, state of São Paulo (Brazil), on the monoclonal antibody eculizumab, and the other by scientists at the ...
Nov 16, 2020
1
115